These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 37511318)

  • 41. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.
    Dallabrida SM; Ismail N; Oberle JR; Himes BE; Rupnick MA
    Circ Res; 2005 Mar; 96(4):e8-24. PubMed ID: 15692086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
    Tayebjee MH; Lim HS; Nadar S; MacFadyen RJ; Lip GY
    Eur J Clin Invest; 2005 Jan; 35(1):8-12. PubMed ID: 15638813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.
    Cheung PY; Sawicki G; Wozniak M; Wang W; Radomski MW; Schulz R
    Circulation; 2000 Apr; 101(15):1833-9. PubMed ID: 10769285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanical transduction of nitric oxide synthesis in the beating heart.
    Pinsky DJ; Patton S; Mesaros S; Brovkovych V; Kubaszewski E; Grunfeld S; Malinski T
    Circ Res; 1997 Sep; 81(3):372-9. PubMed ID: 9285639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.
    Lefer AM; Lefer DJ
    Cardiovasc Res; 1996 Oct; 32(4):743-51. PubMed ID: 8915192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial-leukocyte adhesion molecules.
    Bevilacqua MP
    Annu Rev Immunol; 1993; 11():767-804. PubMed ID: 8476577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism for flow distribution in normal and ischemic myocardium during increased ventricular preload in the dog.
    Kjekshus JK
    Circ Res; 1973 Nov; 33(5):489-99. PubMed ID: 4752851
    [No Abstract]   [Full Text] [Related]  

  • 48. Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue.
    Iida N; Grotendorst GR
    Mol Cell Biol; 1990 Oct; 10(10):5596-9. PubMed ID: 2078213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving Diastolic and Microvascular Function in Heart Transplantation with Donation after Circulatory Death.
    Saemann L; Georgevici AI; Hoorn F; Gharpure N; Veres G; Korkmaz-Icöz S; Karck M; Simm A; Wenzel F; Szabó G
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction Model for Contractile Function of Circulatory Death Donor Hearts Based on Microvascular Flow Shifts During Ex Situ Hypothermic Cardioplegic Machine Perfusion.
    Saemann L; Kohl M; Veres G; Korkmaz-Icöz S; Großkopf A; Karck M; Simm A; Wenzel F; Szabó G
    J Am Heart Assoc; 2022 Dec; 11(23):e027146. PubMed ID: 36382941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donation after circulatory death: current practices, ongoing challenges, and potential improvements.
    Morrissey PE; Monaco AP
    Transplantation; 2014 Feb; 97(3):258-64. PubMed ID: 24492420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart transplantation following donation after circulatory death: Expanding the donor pool.
    Scheuer SE; Jansz PC; Macdonald PS
    J Heart Lung Transplant; 2021 Sep; 40(9):882-889. PubMed ID: 33994229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normothermic Regional Perfusion is an Emerging Cost-Effective Alternative in Donation After Circulatory Death (DCD) in Heart Transplantation.
    Alamouti-Fard E; Garg P; Wadiwala IJ; Yazji JH; Alomari M; Hussain MWA; Elawady MS; Jacob S
    Cureus; 2022 Jun; 14(6):e26437. PubMed ID: 35800191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Machine perfusion of circulatory determined death hearts: A scoping review.
    Saemann L; Guo Y; Ding Q; Zhou P; Karck M; Szabó G; Wenzel F
    Transplant Rev (Orlando); 2020 Jul; 34(3):100551. PubMed ID: 32498975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of machine perfusion preservation of liver grafts from donation after cardiac death.
    Matsuno N; Uchida K; Furukawa H
    Transplant Proc; 2014 May; 46(4):1099-103. PubMed ID: 24815138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Future of heart procurement with donation after circulatory death: Current practice and opportunities for advancement.
    Ayer A; Schroder JN; Casalinova S; Doberne JW; Bryner BS; Patel CB; DeVore AD
    J Heart Lung Transplant; 2022 Oct; 41(10):1385-1390. PubMed ID: 35953351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Donation After Circulatory Death: A New Frontier.
    Joshi Y; Villanueva J; Gao L; Hwang B; Zhao C; Doyle A; Wu J; Jansz P; Macdonald P
    Curr Cardiol Rep; 2022 Dec; 24(12):1973-1981. PubMed ID: 36272050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donation After Circulatory Death: Expanding Heart Transplants.
    Koscik R; Ngai J
    J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3867-3876. PubMed ID: 35831232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abdominal regional in-situ perfusion in donation after circulatory determination of death donors.
    Hessheimer AJ; García-Valdecasas JC; Fondevila C
    Curr Opin Organ Transplant; 2016 Jun; 21(3):322-8. PubMed ID: 27050485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transplantation of Hearts Donated after Circulatory Death.
    White CW; Messer SJ; Large SR; Conway J; Kim DH; Kutsogiannis DJ; Nagendran J; Freed DH
    Front Cardiovasc Med; 2018; 5():8. PubMed ID: 29487855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.